Collectively, these findings indicate that both HDCA and GTE exert anticancer effects through inhibition of mitochondrial and cytosolic heat shock proteins, positioning TRAP1 as a promising therapeutic target for cancer treatment [65]. Here, TRAP1 is linked to cancer.